Fujifilm announced Tuesday that it's beginning phase III trials for its flu drug, Avigan, in coronavirus patients in Japan. It interferes with flu's ability to replicate, and may for COVID-19 too.
from U.S. Home | Mail Online https://ift.tt/39x3NMY
Wednesday, April 1, 2020
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment